1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Global Collaborative Research Training on Non-Communicable Diseases and Disorders Across the Lifespan is sponsored by National Institutes of Health (NIH) - Fogarty International Center. This initiative supports rigorous institutional research training programs for low- and middle-income country (LMIC) scientists that enhance collaborative NIH research with U. S.
scientists on specific noncommunicable diseases (NCDs), disorders, and health conditions.
Get alerted about grants like this
Get emailed when new opportunities from “National Institutes of Health (NIH) - Fogarty International Center” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Global Collaborative Research Training on Non-Communicable Diseases and Disorders Across the Lifespan Global Collaborative Research Training on Non-Communicable Diseases and Disorders Across the Lifespan Agency: National Institutes of Health Assistance Listings: 93. 989 -- International Research and Research Training Last Updated: May 13, 2026 View version history on Grants.
gov This initiative supports rigorous institutional research training programs for low- and middle-income country (LMIC) scientists that enhance collaborative NIH research with U.S. scientists on specific noncommunicable diseases (NCDs), disorders, and health conditions.
Each program should provide research training and mentorship with complementary skills development in data management, scientific presentation and publication, responsible conduct of research and others critical to the NCD focus area. Mentored trainee research projects will leverage collaborative NIH-funded studies in LMICs to better understand the etiology and epidemiology of NCDs in low resource settings.
The NCD focus of each training program must have potential benefit to LMIC health priorities as well as health needs of U.S. populations, and be relevant to the mission of at least one of the participating NIH Institutes, Centers, or Offices.
Applications must specify the special opportunities through the use of unusual talents, resources, populations, or environmental conditions in the proposed LMIC that are not readily available in the U.S., or which augment existing U.S. research resources.
Other Native American tribal organizations Nonprofits non-higher education with 501(c)(3) Nonprofits non-higher education without 501(c)(3) Federally recognized Native American tribal governments City or township governments Special district governments Independent school districts Public and state institutions of higher education Private institutions of higher education Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Grantor contact information Division of International Training and Research (DITR) NCD Program Please contact via e-mail Division of International Training and Research (DITR) NCD Program No documents are currently available.
Link to additional information Estimated Application Due Date : Estimated Due Date Description : Estimated Project Start Date : Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: Eligible applicants include nonprofit organizations, state governments, federally recognized Native American tribal governments, county governments, city or township governments, special district governments, independen…. Confirm the full requirements in the official notice before applying.
The published deadline was July 25, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Global Collaborative Research Training on Non-Communicable Diseases and Disorders Across the Lifespan is funded by National Institutes of Health (NIH) - Fogarty International Center. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward interdisciplinary projects that leverage AI, machine learning, and advanced data science to address pressing questions in biomedical and public health research. It seeks to advance fundamental scientific and engineering contributions across disciplines to solve key health problems.
As of October 1, 2025, NIH no longer posts Notices of Funding Opportunity in the NIH Guide — Grants.gov is now the single official source (NOT-OD-25-143). The weekly Guide table-of-contents email that thousands of investigators relied on to discover funding no longer lists opportunities. Combined with the January 25, 2026 SciENcv certified-PDF requirement, the mechanics of finding and applying for NIH money have changed underneath everyone. Here is how to rebuild your discovery workflow so nothing slips through.
Read articleThe HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleThe NIH Director's New Innovator Award (DP2, RFA-RM-27-002) closes August 17, 2026, offering roughly 30 Early Stage Investigators up to $475,000 in direct costs a year for five years — $2.375 million total — to pursue bold ideas without the preliminary data a standard R01 demands. Here is how the High-Risk, High-Reward program actually evaluates applications, who qualifies, and why the usual R01 instincts will sink you.
Read article